Wockhardt LimitedNSE: WOCKPHARMA

Press Release Aug 13 2021

· Issued by Wockhardt Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

The collaboration aims to facilitate the large-scale manufacturing and supply of these vaccines in India. Dr. Habil Khorakiwala, the Founder Chairman of Wockhardt Group, expressed pride in contributing to the global fight against the pandemic through this partnership. The press release highlights the efficacy of the Sputnik V vaccine, which has been registered in numerous countries worldwide.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Wockhardt Limited on 6ix

Earlier from Wockhardt

Later from Wockhardt

All Wockhardt news releases